Effects of growth hormone and its secretagogues on bone.
作者： Johan Svensson , Sabrina Lall , Suzanne L Dickson , Bengt-Åke Bengtsson , John Rømer
关键词:
摘要: The growth hormone (GH)/insulin-like factor-1 axis is not only of importance for linear body during childhood, but it also one the major determinants adult bone mass. Studies show that GH treatment increases mass in rodents as well GH-deficient humans, effect on healthy humans has so far been impressive. Recently, a new class secretagogues (GHSs) developed. In GHS affects biochemical markers turnover and velocity selected short children with or without deficiency. rodents, increase mineral content, yet shown can affect humans.
springer.com
sci-hub.se 参考文章(51)
B Shapiro, P J Ho, L M Fig, A L Barkan, Bone mineral density of the axial skeleton in acromegaly. The Journal of Nuclear Medicine. ,vol. 33, pp. 1608- 1612 ,(1992)
Susumu Kanzaki, Robert C. Baxter, Raymond Knutsen, David J. Baylink, Subburaman Mohan, Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. Journal of Bone and Mineral Research. ,vol. 10, pp. 854- 858 ,(2009) , 10.1002/JBMR.5650100605
Marie Degerblad, Bengt-Åke Bengtsson, Margareta Bramnert, Olof Johnell, Per Manhem, Thord Rosén, Marja Thorén, Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy. European Journal of Endocrinology. ,vol. 133, pp. 180- 188 ,(1995) , 10.1530/EJE.0.1330180
V. Sibilia, D. Cocchi, F. Pagani, N. Lattuada, G.L. Moro, A. Pecile, A. Rubinacci, E.E. Muller, C. Netti, Hexarelin, a growth hormone – releasing peptide, counteracts bone loss in gonadectomized male rats Growth Hormone & IGF Research. ,vol. 9, pp. 219- 227 ,(1999) , 10.1054/GHIR.1999.0105
P.H. Jørgensen, B. Bak, T.T. Andreassen, Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone. Bone. ,vol. 12, pp. 353- 359 ,(1991) , 10.1016/8756-3282(91)90022-B
T B Hansen, K Brixen, N Vahl, J O Jørgensen, J S Christiansen, L Mosekilde, C Hagen, Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. The Journal of Clinical Endocrinology and Metabolism. ,vol. 81, pp. 3352- 3359 ,(1996) , 10.1210/JCEM.81.9.8784096
Kim Brixen, Moustapha Kassem, Henning K. Nielsen, Anne Gitte Loft, Allan Flyvbjerg, Leif Mosekilde, Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study. Journal of Bone and Mineral Research. ,vol. 10, pp. 1865- 1874 ,(2009) , 10.1002/JBMR.5650101205
Andrew A. Toogood, Judith E. Adams, Paul A. O’Neill, Stephen M. Shalet, Elderly Patients with Adult-Onset Growth Hormone Deficiency Are Not Osteopenic1 The Journal of Clinical Endocrinology & Metabolism. ,vol. 82, pp. 1462- 1466 ,(1997) , 10.1210/JCEM.82.5.3932
T Ono, S Kanzaki, Y Seino, D J Baylink, S Mohan, Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein-3 and -5, and bone alkaline phosphatase isoenzyme. The Journal of Clinical Endocrinology and Metabolism. ,vol. 81, pp. 2111- 2116 ,(1996) , 10.1210/JCEM.81.6.8964836
Harold N. Rosen, Vicki Chen, Antonio Cittadini, Susan L. Greenspan, Pamela S. Douglas, Alan C. Moses, Wesley G. Beamer, Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density Journal of Bone and Mineral Research. ,vol. 10, pp. 1352- 1358 ,(2009) , 10.1002/JBMR.5650100912